News articles from UVA Today.
Meet Allie Donlan, a UVA Researcher Whose Work Has Changed the COVID-19 Fight
Inside the Science of Testing Wastewater at UVA for Evidence of COVID-19
So far, University leaders remain hopeful that the real-time monitoring for the virus markers in dormitory sewage, among other measures, will help UVA avoid the fate of other universities that have had to send students home.
UVA Tests Drug, Given to President Trump, to See If It Can Prevent COVID-19
Researchers are trying to determine if the antibody cocktail used to treat Trump could prevent COVID-19 infection in people who share a household with someone who has tested positive.
UVA Improves Care for Cancers That Have Spread to the Brain
New research offers tools to help doctors and patients make better-informed treatment decisions, enhance the care of brain tumors and coordinate effective interdisciplinary treatment.
Q&A: Researchers Probe How Health of California's Kelp Forests Affects Other Systems
UVA researchers are studying kelp forests off the California coast to understand changes to marine ecosystems.
UVA Reveals How Genetic Differences in Fat Shape Men and Women's Health Risks
New findings about our body fat help explain the differing health risks men and women face – and set the stage for better, more targeted treatments.
Hidden in Plain Sight': Exploring Linguistic Diversity at UVA
A new cross-disciplinary project seeks to explore and celebrate linguistic diversity within the University student body, bringing an overlooked resource to the surface.
COVID-19 Discovery in Children May Inform Development of Vaccines, Treatments
New research links multi-system inflammatory syndrome in children to higher levels of antibodies against a particular part of the COVID-19 virus.
NSF Grant Funding UVA Researchers' Efforts in Arctic Community
Members of UVA's newly formed Arctic Research Center will work directly with residents of Utqiaġvik, Alaska, as they face the effects of climate change.
HIV Drugs Could Prevent Diabetes, Study Suggests
New research shows that the drugs could slash patients' risk of developing Type 2 diabetes by a third.